Clinical trial
Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
NCT03132311 is registered in ClinicalTrials.gov with Oswaldo Cruz Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
- Lead sponsor
- Oswaldo Cruz Foundation
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- May 29, 2017
- Completion date
- December 31, 2028
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.